Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thompson confirmed

This article was originally published in The Tan Sheet

Executive Summary

HHS Secretary Tommy Thompson confirmed in unanimous Senate vote Jan. 24. The 12-year Republican governor of Wisconsin breezed through an easy confirmation process, testifying before the Senate Finance and Health & Education committees the week of Jan. 15 (1"The Tan Sheet" Jan. 22, p. 2)

You may also be interested in...



Thompson lauded on Hill

Wisconsin Gov. Tommy Thompson (R) continued an easy confirmation process Jan. 19, as the HHS secretary-designate received support from both parties at his hearing in front of the Senate Health & Education Committee. HELP Chair Edward Kennedy (D-Mass.) and colleagues heaped praise upon Thompson, similar to the warm welcome he received at his Finance Committee hearing a day earlier. Kennedy summed up his support by saying the Badger State governor "comes to us with a genuinely outstanding record of accomplishment in Wisconsin," referring to his children's health insurance programs and success at welfare reform

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092134

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel